BML Investment Partners, L.P. 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 6:57 pm Sale | 2023-06-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA | BML Investment Partners, L.P. | 0 0.000% | -6,590,000 (Position Closed) | Filing |
| 2023-02-08 4:55 pm Purchase | 2023-02-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA | BML Investment Partners, L.P. | 6,590,000 19.900% | 150,000 (+2.33%) | Filing |
| 2022-11-16 4:45 pm Purchase | 2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA | BML Investment Partners, L.P. | 6,440,000 19.400% | 6,440,000 (New Position) | Filing |